BreastDCEDL is a deep learning–ready DCE-MRI dataset of 2,070 breast cancer patients, sourced from I-SPY1, I-SPY2 and the DUKE cohort.
-
Updated
Jul 1, 2026 - Jupyter Notebook
#
her2
Here are 5 public repositories matching this topic...
Scientific Reports volume 11, Article number: 4037 (2021)
computer-vision deep-learning pytorch digital-pathology breast-cancer her2 trastuzumab whole-slide-image finher finprog
-
Updated
Feb 17, 2021 - Python
Code repository for the article **Leveraging Adversarial Learning for Pathological Fidelity in Virtual Staining (DGM4MICCAI, 2025)**
-
Updated
Jun 8, 2026 - Python
Genomic characterization of HER2 IHC/FISH discordance in breast cancer using TCGA-BRCA data
-
Updated
Mar 25, 2026 - R
Iambic Therapeutics is a San Diego, California AI-driven drug discovery company founded in 2019 by Thomas Miller (CEO) and Fred Manby (CTO) that designs small-molecule therapeutics for oncology and other indications.
drug-discovery enchant structure-prediction oncology biotech san-diego her2 apis-json therapeutics small-molecules protein-ligand ai-drug-discovery multimodal-transformers kif18a cdk2-cdk4 neuralplexer
-
Updated
Aug 19, 2026
Improve this page
Add a description, image, and links to the her2 topic page so that developers can more easily learn about it.
Add this topic to your repo
To associate your repository with the her2 topic, visit your repo's landing page and select "manage topics."